Single-layer versus duct-to-mucosa pancreaticojejunostomy in pyloruspreserving pancreatoduodenectomy for ductal adenocarcinoma—an analysis of a single surgeon’s series

Summary Background Despite considerable efforts there is no consensus regarding the ideal reconstruction method for the pancreatic remnant after pancreaticoduodenectomy (PD). Methods Overall, 86 patients who underwent PD for ductal adenocarcinoma were selected for analysis. One surgeon (RF) took res...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:European surgery 2016-02, Vol.48 (1), p.34-38
Hauptverfasser: Gangl, O., Fröschl, U., Langer, R. M., Függer, R.
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
Beschreibung
Zusammenfassung:Summary Background Despite considerable efforts there is no consensus regarding the ideal reconstruction method for the pancreatic remnant after pancreaticoduodenectomy (PD). Methods Overall, 86 patients who underwent PD for ductal adenocarcinoma were selected for analysis. One surgeon (RF) took responsibility of all pancreatic resections, either by operating personally or proctoring the procedure. The database was prospectively maintained. End-to-side pancreaticojejunostomy (PJ; Group A) was performed from 01/01 to 10/07 and duct-to-mucosa PJ (Group B) from 10/07 to 12/12. Primary endpoints were 30-day mortality, incidence of pancreatic fistulas, and severe complications. Secondary endpoints were severity of pancreatic fistulas, incidence of unplanned reoperation and reintervention and length of stay (LOS). Results 30-day mortality, pancreatic fistula, complication, unplanned reoperation and reintervention rates showed no significant differences (2.2 vs. 2.4 %; 6.7 vs. 0 %; 22.2 vs. 29.3 %; 6.7 vs. 0 %; 11.1 vs. 2.2 %). Summarizing unplanned reoperations and reinterventions, the necessity of any unplanned procedure revealed, a significant reduction from 8 (17.8 %) in Group A to 1 (2.2 %) in Group B ( p  = 0.02). Major complications (Dindo–Clavien Grades III–V) were decreased significantly in Group B (Group A: 9/45 (20 %) vs. Group A: 2/41 (4.9 %); p  = 0.05). LOS was significantly shorter in Group B (15 days, +/− 6.01) as compared with Group A (18 days, +/− 8.87; p  
ISSN:1682-8631
1682-4016
DOI:10.1007/s10353-015-0373-1